Sightsavers awarded grant to fight neglected tropical diseases in Guinea-Bissau
The Astellas Global Health Foundation has awarded Sightsavers a grant of US$536,700 to help treat four neglected tropical diseases in Guinea-Bissau.
The grant will enable Sightsavers to distribute one million treatments to combat river blindness, lymphatic filariasis, schistosomiasis and intestinal worms in six endemic areas of the country.
More than 1.2 million people are at risk of infection in Guinea-Bissau and the treatments will help reduce the morbidity, mortality and disability associated with the debilitating diseases. Once they’re protected through medication, children can continue their education and adults can earn a living and support their families.
The Astellas Global Health Foundation is an international philanthropic organisation that focuses on improving access to health care, building community resilience and providing disaster support around the world. Sightsavers is one of five organisations that will benefit from the foundation’s latest grants, which will total US$3.9 million.
Read all our latest news stories
News from Sightsavers
Sightsavers responds to report into FCDO’s work on disability inclusion
A report on the UK government’s development strategy and how inclusive it is of people with disabilities was published on Thursday 4 April.
Sightsavers’ Accelerate programme gets US$36.5 million funding boost to banish trachoma
The extra funding from international donors will help speed up the elimination of trachoma in Africa by expanding and extending the programme.
Sightsavers at the CIES education conference 2024
We're attending the conference in Miami on 6-14 March to share our expertise, engage with the education community and explore how we can transform inclusive education.
Inspirational stories direct to your inbox
Inspirational stories direct to your inbox
Want to hear more from Sightsavers? Join more than 170,000 supporters who receive inspiring emails about life-changing projects and ways to support our work.
You will receive regular updates about our work and can unsubscribe at any time by clicking the link in each newsletter, or by emailing [email protected]
For more information see our privacy policy
